Low Dose Rivaroxaban for Atherosclerotic Cardiovascular Diseases: A Systematic Review and Meta-analysis

• প্রধান লেখক: Can Chen (লেখক), Yuanqing Kan (লেখক), Zhenyu Shi (লেখক), Daqiao Guo (লেখক), Weiguo Fu (লেখক), Yanli Li (লেখক), Qianzhou Lv (লেখক), Xiaoyu Li (লেখক), Yi Si (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Frontiers Media S.A., 2021-02-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Background: This study aims to explore the role of low-dose rivaroxaban (≤10 mg daily) for the treatment of atherosclerotic cardiovascular disease (ASCVD).Methods: PubMed, Embase and the Cochrane Library were searched for randomized controlled trials (RCTs) of low-dose rivaroxaban in patients with A...